Zhirong Yang Selected Research

lanatoside C

1/2022

The Clinical Efficacy of Cedilanid and Isosorbide Dinitrate plus Pericardial Dissection for Chronic Constrictive Pericarditis in the Elderly and Its Influence on Plasma Endothelin, Atrial Natriuretic Peptide, and Systemic Immune-Inflammation Index.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Zhirong Yang Research Topics

Disease

14	Type 2 Diabetes Mellitus (MODY) 12/2019 - 01/2012
11	Neoplasms (Cancer) 10/2019 - 09/2006
4	Stroke (Strokes) 06/2022 - 01/2019
4	Dementia (Dementias) 06/2022 - 01/2019
4	Inflammation (Inflammations) 01/2022 - 01/2003
4	Tuberculosis (Tuberculoses) 01/2013 - 01/2011
3	Hypertension (High Blood Pressure) 01/2019 - 10/2015
2	Colonic Neoplasms (Colon Cancer) 01/2021 - 02/2010
2	Cognitive Dysfunction 12/2020 - 01/2020
2	Breast Neoplasms (Breast Cancer) 01/2016 - 07/2013
2	Chemical and Drug Induced Liver Injury 03/2015 - 01/2013
2	Drug-Related Side Effects and Adverse Reactions 01/2013 - 09/2012
1	Pancreatic Neoplasms (Pancreatic Cancer) 06/2022
1	Constrictive Pericarditis 01/2022
1	Genomic Instability 01/2021
1	Alzheimer Disease (Alzheimer's Disease) 12/2020
1	COVID-19 01/2020
1	Acne Vulgaris 01/2020
1	Pruritus (Itching) 01/2020
1	Atherosclerosis 01/2020
1	Dermatitis 01/2020
1	Hypersensitivity (Allergy) 01/2020
1	Erythema 01/2020
1	Exanthema (Rash) 01/2020
1	Headache (Headaches) 12/2019
1	Neurologic Manifestations (Neurological Manifestations) 12/2019
1	Dizziness (Lightheadedness) 12/2019
1	Ischemic Stroke 01/2019
1	Anemia 01/2019
1	Transient Ischemic Attack 01/2019
1	Coronary Disease (Coronary Heart Disease) 01/2019
1	Digestive System Neoplasms (Cancer of the Digestive System) 01/2019
1	Fibrosis (Cirrhosis) 01/2019
1	Gastrointestinal Neoplasms (Gastrointestinal Cancer) 01/2019
1	Insulin Resistance 01/2019
1	Neutropenia 01/2019
1	Obesity 01/2019
1	Autoimmune Hepatitis 01/2019
1	Hyperglycemia 12/2018
1	Bone Fractures (Bone Fracture) 01/2017
1	Vascular System Injuries 01/2017
1	Coma (Comas) 01/2017
1	Carcinogenesis 07/2016
1	Ovarian Epithelial Carcinoma 07/2016

Drug/Important Bio-Agent (IBA)

10	Glucagon-Like Peptide-1 Receptor AgonistsIBA 12/2019 - 01/2012
5	Hypoglycemic Agents (Hypoglycemics)IBA 12/2019 - 01/2015
4	Glucagon-Like Peptide 1 (GLP 1)IBA 12/2019 - 01/2012
4	IncretinsIBA 12/2019 - 03/2018
4	Biosimilar PharmaceuticalsIBA 10/2019 - 01/2019
3	Pharmaceutical PreparationsIBA 06/2022 - 09/2006
3	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 06/2022 - 01/2019
3	LipidsIBA 01/2022 - 01/2015
3	ThiazolidinedionesIBA 12/2019 - 01/2016
3	Insulin (Novolin)FDA Link 12/2019 - 01/2016
3	Glucose (Dextrose)FDA LinkGeneric 01/2019 - 01/2018
3	kallistatinIBA 01/2017 - 07/2013
3	Antitubercular AgentsIBA 01/2013 - 01/2011
2	Triglycerides (Triacylglycerol)IBA 01/2022 - 01/2018
2	Long Noncoding RNAIBA 01/2021 - 07/2016
2	Biomarkers (Surrogate Marker)IBA 01/2021 - 01/2019
2	Metformin (Glucophage)FDA LinkGeneric 01/2019 - 12/2018
2	Proteins (Proteins, Gene)FDA Link 01/2017 - 01/2016
2	CateninsIBA 01/2016 - 07/2013
2	Exenatide (Byetta)FDA Link 10/2015 - 01/2012
2	EnzymesIBA 03/2015 - 01/2013
1	CyclinsIBA 06/2022
1	Gemcitabine FDA Link 06/2022
1	Deoxycytidine KinaseIBA 06/2022
1	LDL CholesterolIBA 01/2022
1	oxidized low density lipoproteinIBA 01/2022
1	Atrial Natriuretic Factor (ANF)IBA 01/2022
1	Endothelins (Endothelin)IBA 01/2022
1	Isosorbide Dinitrate (Isordil)FDA LinkGeneric 01/2022
1	HDL CholesterolIBA 01/2022
1	lanatoside CIBA 01/2022
1	Hydrocortisone (Cortisol)FDA LinkGeneric 12/2020
1	Clindamycin (Cleocin)FDA LinkGeneric 01/2020
1	Benzoyl Peroxide FDA LinkGeneric 01/2020
1	Adapalene (Differin)FDA LinkGeneric 01/2020
1	Salicylic Acid (2 Hydroxybenzoic Acid)FDA LinkGeneric 01/2020
1	Indicators and Reagents (Reagents)IBA 01/2020
1	Erythromycin (Erycette)FDA LinkGeneric 01/2020
1	ORALIT (ORS)IBA 12/2019
1	6,6'- (ethylenebis(oxyethyleneimino))bis(17- cyclopropylmethyl)- 4,5- epoxymorphinan- 3,14- diolIBA 10/2019
1	Glycoside Hydrolase InhibitorsIBA 01/2019
1	pegfilgrastim (Neulasta)FDA Link 01/2019
1	Epoetin Alfa (Epogen)FDA Link 01/2019
1	Filgrastim (Neupogen)FDA Link 01/2019
1	C-PeptideIBA 01/2019
1	Colony-Stimulating Factors (Colony Stimulating Factor)IBA 01/2019
1	SodiumIBA 01/2019
1	SymportersIBA 01/2019
1	Dipeptidyl-Peptidase IV InhibitorsIBA 09/2017
1	LinagliptinIBA 01/2017
1	alogliptinIBA 01/2017
1	saxagliptin FDA Link 01/2017

Therapy/Procedure

6	Therapeutics 12/2019 - 01/2013
3	Glycemic Control 12/2018 - 12/2012
2	Drug Therapy (Chemotherapy) 06/2022 - 01/2019
1	Tracheotomy 01/2017